NCT07174141
- Conditions
- Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)
- Locations
-
- CHU Dijon Bourgogne Dijon, France
Clinical trial condition
Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)
Explore clinical trials studying Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib). Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study